ONtrepreneurs Program

Program Offerings

Up to 10 ONtrepreneurs awarded annually for the 12-month program

  • $50,000

    Non-dilutive fund. OBI does not take equity or IP

  • Training

    Training opportunities to build your venture

  • Mentorship

    1:1 mentorship from an expert in your sector

  • OBI Network

    Value-add opportunities as part of our network

Impact of our work

The ONtrepreneurs program is fueling the growth of the neurotech cluster.

  • 57

    ONtrepreneurs*

  • 95.4M

    Follow-on Investments*

  • 33X

    Return on Investments*

Epineuron Technologies Closes Financing for its Breakthrough Nerve Regeneration Device

Epineuron Technologies, Inc., a bioelectronic medicine company, announced the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.

Spiderwort Closes $3.4 Million Cad in Seed Financing

Spiderwort, an Ottawa-based healthtech and biomaterials startup, has raised a seed round of funding at $3.4 million CAD ($2.5 million USD).

Spiderwort is developing a new biomaterial that uses plant-derived cellulose to create a variety of “scaffold architectures” for regenerative medicine. It is currently in the pre-clinical stage of this product. The startup plans to use the funding to continue its work towards clinical trials, which it called “key” to bringing its biomaterial to market.

Bringing New Technology to Life - A Giant Leap for Elder Care

In the most rewarding relationships, everyone brings something to the table. When OBI partners with other organizations, we consider the ways each party can be of value to a mutually shared goal.

The Welbi platform is a perfect example. The innovation of an innovative Ottawa startup, Welbi helps senior living communities reduce social isolation, and acts as a personal assistant automating administrative tasks, providing alerts and making recommendations to staff so that they can better tailor their services to the needs of their community.

Nanology Labs Win $200,000

Congratulations to OBI’s ONtrepreneur, Mohammad Amini from Nanology Labs on winning the 2020 MEDTEQ Innovation Summit of $200,000.

Nanology Labs is developing safe and smart MRI contrast agents for early detection of brain tumors. A revolutionary non-toxic MRI contrast agent Manganescan™, uses the element manganese to illuminate early stage tumors, specifically in the brain. Early stage detection provides clinicians advance knowledge for diagnosis, better treatment options.

Neurotech Spotlight

Epineuron Technologies Closes Financing for its Breakthrough Nerve Regeneration Device

Epineuron Technologies, Inc., a bioelectronic medicine company, announced the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.

Investors

Private and institutional investors interested in learning more about the neurotech industry or considering investments in this space can gain access to OBI’s investor platform with detailed profiles of OBI’s portfolio companies. To learn more, please contact: IndustryRelations@braininstitute.ca

Neurotechnology Startups

If you are commercializing a neurotechnology we want to hear from you. Contact us to learn more about the neurotech industry and OBI’s commercialization programs and opportunities: IndustryRelations@braininstitute.ca

*Cumulative total as of Mar 31, 2020